Arbitrage SBIR Vendor Procurement via Consortium Discounts
- Organization
- National Science Foundation (NSF)
- Sector
- SBIR Phase I biotech awardees with urgent vendor procurement needs
- Location
- San Diego, CA
Source reference
Executive summary
Current state
NSF SBIR Phase I award provides AICONIC BIOSCIENCES with $305,000 non-dilutive funding for gene therapy platform development but creates structural commercial gaps between their $350M revenue projection and the grant's 18-month, vendor-constrained scope.
Market catalyst
SBIR Phase I awardees have $305K that must be spent on vendors within 18 months but lack procurement sophistication to negotiate bulk discounts, creating a 15-20% margin opportunity for a procurement aggregator.
This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.
Field notes
Intelligence ledger
Add new evidence, corrections, or practical context to this directive. Keep claims attributable to a source where possible.
Sign in to add intelligence or vote on a field note.
Field intel logs: [ 0 ] entries. No operative updates submitted for this directive. Submit intel to claim clearance.